Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109354784 | 10935478 | 4 | F | 20141229 | 20160815 | 20150320 | 20160818 | EXP | JP-GLAXOSMITHKLINE-JP2015JPN014914 | GLAXOSMITHKLINE | 86.24 | YR | F | Y | 51.00000 | KG | 20160818 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109354784 | 10935478 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 50 MG, QD | Y | 20241 | TABLET | ||||||||
| 109354784 | 10935478 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 50 MG, QD | Y | 20241 | 50 | MG | TABLET | QD | |||||
| 109354784 | 10935478 | 3 | SS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | UNK | Y | 0 | |||||||||
| 109354784 | 10935478 | 4 | C | DERMOSOL-G | 2 | UNK, BID | 0 | BID | |||||||||||
| 109354784 | 10935478 | 5 | C | MEMARY | MEMANTINE HYDROCHLORIDE | 1 | 5 MG, QD | 0 | 20 | MG | QD | ||||||||
| 109354784 | 10935478 | 6 | C | CALFINA | ALFACALCIDOL | 1 | 1.0 ?G, QD | 0 | 1 | UG | QD | ||||||||
| 109354784 | 10935478 | 7 | C | ASPARA-CA | CALCIUM ASPARTATE | 1 | 200 MG, QD | 0 | 200 | MG | QD | ||||||||
| 109354784 | 10935478 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 109354784 | 10935478 | 9 | C | LORATADINE. | LORATADINE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 109354784 | 10935478 | 10 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | 2 DF, BID | 0 | 1 | DF | BID | ||||||||
| 109354784 | 10935478 | 11 | C | CLIMAGEN | FAMOTIDINE | 1 | 20 MG, BID | 0 | 20 | MG | BID | ||||||||
| 109354784 | 10935478 | 12 | C | CHINESE MEDICINE | UNSPECIFIED INGREDIENT | 1 | 2.5 G, TID | 0 | 2.5 | G | TID | ||||||||
| 109354784 | 10935478 | 13 | C | TULOBUTEROL | TULOBUTEROL | 1 | 2 MG, QD | 0 | 2 | MG | QD | ||||||||
| 109354784 | 10935478 | 14 | C | CHINESE MEDICINE | UNSPECIFIED INGREDIENT | 1 | 1 DF, TID | 0 | 1 | DF | TID | ||||||||
| 109354784 | 10935478 | 15 | C | DERMOVATE | CLOBETASOL | 1 | UNK, BID | 0 | BID | ||||||||||
| 109354784 | 10935478 | 16 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 2 G, TID | 0 | 2 | G | TID | ||||||||
| 109354784 | 10935478 | 17 | C | ASPARA POTASSIUM | POTASSIUM ASPARTATE | 1 | 1.2 G, TID | 0 | 1.2 | G | TID | ||||||||
| 109354784 | 10935478 | 18 | C | WHITE PETROLATUM | PETROLATUM | 1 | UNK, QD | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109354784 | 10935478 | 1 | Epilepsy |
| 109354784 | 10935478 | 3 | Antiviral prophylaxis |
| 109354784 | 10935478 | 5 | Dementia Alzheimer's type |
| 109354784 | 10935478 | 6 | Osteoporosis |
| 109354784 | 10935478 | 7 | Mineral supplementation |
| 109354784 | 10935478 | 8 | Diuretic therapy |
| 109354784 | 10935478 | 9 | Hypersensitivity |
| 109354784 | 10935478 | 12 | Diuretic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109354784 | 10935478 | DE |
| 109354784 | 10935478 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109354784 | 10935478 | Blood albumin decreased | |
| 109354784 | 10935478 | Blood beta-D-glucan increased | |
| 109354784 | 10935478 | Conjunctival hyperaemia | |
| 109354784 | 10935478 | Drug eruption | |
| 109354784 | 10935478 | Erythema | |
| 109354784 | 10935478 | Erythema of eyelid | |
| 109354784 | 10935478 | Eyelid erosion | |
| 109354784 | 10935478 | Fungal infection | |
| 109354784 | 10935478 | General physical health deterioration | |
| 109354784 | 10935478 | Hypercatabolism | |
| 109354784 | 10935478 | Lip erosion | |
| 109354784 | 10935478 | Ocular hyperaemia | |
| 109354784 | 10935478 | Oral mucosa erosion | |
| 109354784 | 10935478 | Pigmentation disorder | |
| 109354784 | 10935478 | Rash | |
| 109354784 | 10935478 | Rash generalised | |
| 109354784 | 10935478 | Rash maculo-papular | |
| 109354784 | 10935478 | Scab | |
| 109354784 | 10935478 | Skin erosion | |
| 109354784 | 10935478 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109354784 | 10935478 | 1 | 20141204 | 0 | ||
| 109354784 | 10935478 | 2 | 20150124 | 0 | ||
| 109354784 | 10935478 | 3 | 20141228 | 20141229 | 0 | |
| 109354784 | 10935478 | 4 | 20141109 | 0 | ||
| 109354784 | 10935478 | 5 | 20150123 | 0 | ||
| 109354784 | 10935478 | 6 | 20150124 | 0 | ||
| 109354784 | 10935478 | 7 | 20150124 | 0 | ||
| 109354784 | 10935478 | 8 | 20150124 | 0 | ||
| 109354784 | 10935478 | 9 | 20150124 | 0 | ||
| 109354784 | 10935478 | 10 | 20150124 | 0 | ||
| 109354784 | 10935478 | 11 | 20150124 | 0 | ||
| 109354784 | 10935478 | 12 | 20150124 | 0 | ||
| 109354784 | 10935478 | 13 | 20150124 | 0 | ||
| 109354784 | 10935478 | 14 | 20150124 | 0 | ||
| 109354784 | 10935478 | 16 | 20150219 | 0 | ||
| 109354784 | 10935478 | 17 | 20150213 | 0 | ||
| 109354784 | 10935478 | 18 | 20150213 | 0 |